Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CTSA | P10619 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | KDM1A | O60341 | 1/20 | 0.37 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.36 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30041316 | 1.00 | GRM5 (0.51) | GRM5ALDH1A1HPGDIRAK4KDM4E | |
| SCHEMBL455687 | 0.84 | KDM4E (0.59) | ALDH1A1IRAK4KDM4EALOX15TSHR | |
| Acetic Acid SCHEMBL28860398 | 0.83 | KDM4E (0.61) | GRM5ALDH1A1HPGDKDM4EALOX15 | |
| SCHEMBL960010 | 0.82 | ALDH1A1 (0.51) | GRM5ALDH1A1HPGDKDM4EALOX15 | |
| SCHEMBL6641842 | 0.81 | KDM4E (0.56) | ALDH1A1IRAK4KDM4EALOX15TSHR | |
| SCHEMBL13932169 | 0.80 | KDM4E (0.50) | GRM5ALDH1A1HPGDKDM4EALOX15 | |
| SCHEMBL4989 | 0.80 | KDM4E (0.70) | GRM5ALDH1A1HPGDKDM4EALOX15 | |
| SCHEMBL29940784 | 0.80 | KDM4E (0.70) | GRM5ALDH1A1HPGDKDM4EALOX15 | |
| Hydrochloric Acid SCHEMBL28930333 | 0.79 | ALDH1A1 (0.58) | ALDH1A1IRAK4KDM4EALOX15TSHR | |
| SCHEMBL25307554 | 0.78 | ALDH1A1 (0.49) | GRM5ALDH1A1HPGDKDM4EALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 711 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122080087-A | Pyridine-imine type metal complex and preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-118724797-B | Terpyridyl zinc complex and preparation method and application thereof | 中南大学 | 2026-05-12 | — | — | CN | claimed |
| CN-120020141-A | Iron-based complex, ethylene oligomerization catalyst composition and preparation method thereof | 中国石油天然气股份有限公司 | 2025-05-20 | — | — | CN | claimed |
| CN-119638727-A | Terpyridyl zinc complex and preparation method and application thereof | 中南大学 | 2025-03-18 | — | — | CN | claimed |
| CN-119569647-A | Buried material compound and application thereof in perovskite battery | 厦门紫金新能源新材料科技有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-119101093-A | Nickel (II) picolinate catalyst containing axially flexible cycloalkyl and application thereof in hyperbranched polyethylene lubricating oil synthesis | 合肥烯珩新型催化材料有限公司 | 2024-12-10 | — | — | CN | claimed |
| CN-118724797-A | Terpyridyl zinc complex and preparation method and application thereof | 中南大学 | 2024-10-01 | — | — | CN | claimed |
| CN-115594665-A | Novel preparation method of rasemiptan | 北京万全德众医药生物技术有限公司（CN） | 2023-01-13 | — | — | CN | claimed |
| CN-114773614-A | Bimetal controllable distribution supramolecular material and preparation method thereof | 吉林大学 | 2022-07-22 | — | — | CN | claimed |
| CN-114106055-A | Butterfly alkene modified double tridentate iridium complex, preparation method and organic electroluminescent device | 安徽工业大学 | 2022-03-01 | — | — | CN | claimed |
| CN-104313075-A | Cell production method for photoactive bromopyridyl ethanol | UNIV QINGDAO SCIENCE & TECHNOLOGY | 2015-01-28 | — | — | CN | claimed |
| CN-102942429-A | Method for preparing aza or thia aryl biaryl compound by palladium-carbon catalysis | UNIV DALIAN TECH | 2013-02-27 | — | — | CN | claimed |
| CN-102491968-A | Method for preparing carbazolyl biaryl compound in water phase | UNIV DALIAN TECH | 2012-06-13 | — | — | CN | claimed |
| CN-101948366-A | Method for preparing 4- (diphenylamino) biaryl compound in water phase | UNIV DALIAN TECH | 2011-01-19 | — | — | CN | claimed |
| CN-122080087-A | Pyridine-imine type metal complex and preparation method and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| US-20260138956-A1 | NOVEL COMPOUNDS AND USES THEREOF | RECURSION PHARMACEUTICALS INC (US) | 2026-05-21 | — | — | US | disclosed |
| EP-4745212-A1 | NEW COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME | TOP RUN MATERIAL SOLUTION Co., Ltd. (KR) | 2026-05-20 | — | — | EP | disclosed |
| US-5350696-A | 2-acetyl-6-cyanopyridines and their use as intermediates in the synthesis of oligo-2,6-pyridines | STERLING WINTHROP, INC. (US) | 1994-09-27 | — | — | US | disclosed |
| WO-1993021957-A1 | COMPLEXING AGENTS AND TARGETING IMMUNOREAGENTS | STERLING WINTHROP INC. (US) | 1993-11-11 | — | — | WO | disclosed |
| WO-1992008494-A2 | TARGETING RADIOACTIVE IMMUNOREAGENTS | STERLING WINTHROP INC. (US) | 1992-05-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260138956-A1 | NOVEL COMPOUNDS AND USES THEREOF | SLC10A1, NR3C2, CYP2C8 | GRM5 497/4885ALDH1A1 230/4885HPGD 932/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.